Association of Centre of Excellence Self- Administered Questionnaire Score and Frailty Levels

Active, not recruiting

• Conditions: Fall Injury; Frailty; Cognitive Decline; Injuries

• Registration Number: NCT03991806
• Lead Sponsor: Jewish General Hospital

Brief Summary

This study evaluates the frailty and the health adverse events in the population of the Canadian Longitudinal Study on Aging. It will be used the Centre of Excellence Self-Administered questionnaire (CESAM) which assesses frailty of older adults by providing a score and a of frailty in 4 levels.

Detailed Description

Age is broadly recognized to confer a risk for health adverse outcomes, but it is an insensitive and non-specific measure for use in individual decision-making. Frailty has been emerging to take its rightful place as a better measure for over past decades. Despite general consensus that the concept of frailty is clinically useful, the lack of agreement on its definition and the challenge of its measurement by front-line health providers mean that frailty remains only 'their apparent' to chronological age as a criterion to select older persons at risk.

Study Timeline

• Study First Submitted: 2019-06-14
• Study First Submitted QC: 2019-06-18
• Study First Posted: 2019-06-19
• Study Start: 2020-05-31
• Status Verified: 2024-02
• Last Update Submitted: 2024-02-22
• Last Update Posted: 2024-02-23
• Primary Completion: 2024-12-31
• Study Completion: 2025-08-31

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 30000

Inclusion Criteria

• Being 65 years and over
• Being enrolled in the Canadian Longitudinal Study on Aging

Exclusion Criteria

• Never being enrolled in the Canadian Longitudinal Study on Aging
• Undisclosed health adverse events

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Dementia	around 18 months	The algorithm is a three- step process involving administration of the neuropsychological battery to develop composite score in the three domains-memory, executive function, and psychomotor speed.; The primary outcome of the study will be to determine the number of participants to whom the memory, the executive function, and the psychomotor speed are affected.

Secondary Outcome Measures

Name	Time	Method
Medication	around 18 months	In the maintaining contact interview, one question will be asked of all participants in relation to prescription medication use in the preceding month. A second question asks about the frequency of prescription drug use during this month.; The secondary outcome of the study will be to determine the number of the medication that the participant take during a period of time.

Trial Locations

Locations (1)

Jewish General Hospital; 🇨🇦 Montréal, Quebec, Canada